Table 4.
Complications and treatments of recovered and deceased patients with COVID-19
| Total (n=2719) | Survivors (n=2610) | Non-survivors (n=109) | P value | |
|---|---|---|---|---|
| Complications | ||||
| Respiratory failure | 131 (4.8) | 68 (2.6) | 63 (57.8) | <0.001* |
| Acute respiratory distress syndrome | 63 (2.3) | 34 (1.3) | 29 (26.6) | <0.001* |
| Acute cardiac injury | 89 (3.3) | 72 (2.8) | 17 (15.6) | <0.001* |
| Acute kidney injury | 96 (3.5) | 85 (3.3) | 11 (10.1) | 0.001* |
| Septic shock | 71 (2.6) | 31 (1.2) | 40 (36.7) | <0.001* |
| Treatments | ||||
| Antibiotic treatment | 1497 (55.1) | 1401 (53.7) | 96 (88.1) | <0.001* |
| Antiviral treatment | 1720 (63.3) | 1645 (63.0) | 75 (68.8) | 0.220 |
| Glucocorticoid treatment | 365 (13.4) | 288 (11.0) | 77 (70.6) | <0.001* |
| Traditional Chinese medicines treatment | 2170 (79.8) | 2088 (80.0) | 82 (75.2) | 0.224 |
| Intravenous immunoglobin treatment | 169 (6.2) | 129 (4.9) | 40 (36.6) | <0.001* |
| Targeted immunomodulatory treatment | 102 (3.8) | 85 (3.3) | 17 (15.6) | <0.001* |
| COVID-19 convalescent plasma treatment | 101 (3.7) | 96 (3.7) | 5 (4.6) | 0.600 |
| Oxygen therapy | 1901 (70.0) | 1819 (70.0) | 82 (75.2) | 0.217 |
| Non-invasive mechanical ventilation | 243 (8.9) | 210 (8.0) | 33 (30.3) | <0.001* |
| Invasive mechanical ventilation | 166 (6.1) | 98 (3.8) | 68 (62.3) | <0.001* |
| Continuous renal replacement therapy (CRRT) | 30 (1.1) | 17 (0.7) | 13 (11.9) | <0.001* |
| Extracorporeal membrane oxygenation (ECMO) | 2 (0.7) | 0 (0.0) | 2 (1.8) | <0.001* |
Data are median (IQR), n (%), or n/N (%). Definition of abbreviation: COVID-19: coronavirus disease 2019.